Literature DB >> 7867134

Childhood vaccination coverage in Italy: results of a seven-region survey. The Italian Vaccine Coverage Survey Working Group.

.   

Abstract

In Italy few data exist on vaccination coverage and timeliness. We therefore carried out cluster surveys on 12-23-month-olds in nine Italian cities and regions using standard Expanded Programme on Immunization methodology. The study areas accounted for 40% of all live births in Italy in 1991. Coverage levels for the third dose of diphtheria and tetanus toxoids and for oral poliovirus vaccine, which are mandatory, exceeded 90% in all but one area. However, less than two-thirds of the children had completed the primary vaccine series by their first birthday. The commonest reason for failure to complete the series in time was that the child had been sick and was not brought for vaccination. For the two optional vaccines (pertussis and measles) coverage was much poorer, ranging from 8% to 71% for pertussis and from 9% to 53% for measles. The commonest reason given by the mothers for pertussis non-vaccination was that they had been advised against it, while for measles the commonest reasons were that the child was sick and that they had been advised against it. These findings suggest that although coverage for the mandatory vaccines is high, coverage for pertussis and measles is very low. Additional education of physicians and mothers is needed concerning the true contraindications for vaccination. Also, in the absence of legislation making pertussis and measles vaccines mandatory, greater efforts are needed to convince physicians and the public about the benefits of their use.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7867134      PMCID: PMC2486744     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  6 in total

1.  Epidemiology of pertussis in a developed country with low vaccination coverage: the Italian experience.

Authors:  N J Binkin; S Salmaso; A E Tozzi; G Scuderi; D Greco; D Greco
Journal:  Pediatr Infect Dis J       Date:  1992-08       Impact factor: 2.129

2.  Preventive care for children: immunization in England and Wales.

Authors:  S Goodwin
Journal:  Pediatrics       Date:  1990-12       Impact factor: 7.124

3.  Immunization coverage among preschool children: the United States and selected European countries.

Authors:  B C Williams
Journal:  Pediatrics       Date:  1990-12       Impact factor: 7.124

4.  Immunizations in the United States.

Authors:  A R Hinman
Journal:  Pediatrics       Date:  1990-12       Impact factor: 7.124

Review 5.  Immunisation practice in developed countries.

Authors:  A R Hinman; W A Orenstein
Journal:  Lancet       Date:  1990-03-24       Impact factor: 79.321

6.  Immunization coverage in Italy.

Authors:  S Salmaso; M A Stazi; S Luzi; D Greco
Journal:  Bull World Health Organ       Date:  1987       Impact factor: 9.408

  6 in total
  13 in total

1.  Long-term pertussis-specific immunity after primary vaccination with a combined diphtheria, tetanus, tricomponent acellular pertussis, and hepatitis B vaccine in comparison with that after natural infection.

Authors:  S Esposito; T Agliardi; A Giammanco; G Faldella; A Cascio; S Bosis; O Friscia; M Clerici; N Principi
Journal:  Infect Immun       Date:  2001-07       Impact factor: 3.441

2.  Diphtheria antitoxin levels in the 14-30-year age group in Italy.

Authors:  I Mastroeni; A M Patti; A L Santi; N Vescia; S Bocchini; S Bagnod; C Ciapetti; G M Fara
Journal:  Eur J Epidemiol       Date:  1998-10       Impact factor: 8.082

3.  Low prevalence of diphtheria immunity in the population of Florence, Italy.

Authors:  N Comodo; P Bonanni; A Lo Nostro; E Tiscione; F Mannelli; A Tomei
Journal:  Eur J Epidemiol       Date:  1996-06       Impact factor: 8.082

Review 4.  Progress in the elimination of measles and congenital rubella in Central Italy.

Authors:  Angela Bechini; Miriam Levi; Sara Boccalini; Emilia Tiscione; Donatella Panatto; Daniela Amicizia; Paolo Bonanni
Journal:  Hum Vaccin Immunother       Date:  2013-01-04       Impact factor: 3.452

5.  Parents as source of pertussis transmission in hospitalized young infants.

Authors:  Giorgio Fedele; Maria Carollo; Raffaella Palazzo; Paola Stefanelli; Elisabetta Pandolfi; Francesco Gesualdo; Alberto Eugenio Tozzi; Rita Carsetti; Alberto Villani; Ambra Nicolai; Fabio Midulla; Clara Maria Ausiello
Journal:  Infection       Date:  2016-09-10       Impact factor: 3.553

6.  Surveillance of acute flaccid paralysis in Italy: 1996-1997. AFP Study Group. Acute flaccid paralysis.

Authors:  L Fiore; F Novello; P Simeoni; C Amato; L Vellucci; D De Stefano; M E Grandolfo; I Luzzi
Journal:  Eur J Epidemiol       Date:  1999-09       Impact factor: 8.082

7.  Choosing immunisation coverage indicators at the local level.

Authors:  Paolo Giorgi Rossi; Annunziata Faustini; Teresa Spadea; Carlo A Perucci
Journal:  Eur J Epidemiol       Date:  2004       Impact factor: 8.082

8.  Sero-epidemiology of hepatitis B markers in the population of Tuscany, Central Italy, 20 years after the implementation of universal vaccination.

Authors:  Sara Boccalini; Elettra Pellegrino; Emila Tiscione; Giovanna Pesavento; Angela Bechini; Miriam Levi; Stefano Rapi; Stefano Mercurio; Francesco Mannelli; Marta Peruzzi; Cesare Berardi; Paolo Bonanni
Journal:  Hum Vaccin Immunother       Date:  2013-01-25       Impact factor: 3.452

9.  Congenital rubella infection following rubella outbreak in northern Italy, 2002: need for an effective vaccination programme.

Authors:  M G Revello; G Gorini; M Zavattoni; M Furione; G Gerna
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-10       Impact factor: 3.267

10.  Pertussis over two decades: seroepidemiological study in a large population of the Siena Province, Tuscany Region, Central Italy.

Authors:  Geraldo Tadinho Monteverde Spencer; Angela Azzarello; Serena Marchi; Emanuele Montomoli; Edmond J Remarque; Simonetta Viviani; Claudia Maria Trombetta
Journal:  BMJ Open       Date:  2019-10-30       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.